Kevin Ali - 31 Mar 2025 Form 4 Insider Report for Organon & Co. (OGN)

Role
Chief Executive Officer, Director
Signature
/s/ Tarnetta V. Jones, as Attorney-in-Fact for Kevin Ali
Issuer symbol
OGN
Transactions as of
31 Mar 2025
Net transactions value
-$876,288
Form type
4
Filing time
02 Apr 2025, 17:32:00 UTC
Previous filing
24 Feb 2025
Next filing
06 May 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction OGN Common Stock Options Exercise $0 +48,758 +24% $0.000000 248,677 31 Mar 2025 Direct
transaction OGN Common Stock Tax liability $391,248 -26,964 -11% $14.51 221,713 31 Mar 2025 Direct F1
transaction OGN Common Stock Options Exercise $0 +38,974 +18% $0.000000 260,687 31 Mar 2025 Direct
transaction OGN Common Stock Tax liability $312,734 -21,553 -8.3% $14.51 239,134 31 Mar 2025 Direct F1
transaction OGN Common Stock Options Exercise $0 +21,472 +9% $0.000000 260,606 31 Mar 2025 Direct
transaction OGN Common Stock Tax liability $172,306 -11,875 -4.6% $14.51 248,731 31 Mar 2025 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction OGN Stock Option (right to buy) Award $0 +1,072,607 $0.000000 1,072,607 31 Mar 2025 Common Stock 1,072,607 $14.89 Direct F2
transaction OGN Restricted Stock Units Award $0 +218,267 $0.000000 218,267 31 Mar 2025 Common Stock 218,267 Direct F3, F4
transaction OGN Restricted Stock Units Options Exercise $0 -48,758 -33% $0.000000 97,518 31 Mar 2025 Common Stock 48,758 Direct F3, F5
transaction OGN Restricted Stock Units Options Exercise $0 -38,974 -50% $0.000000 38,974 31 Mar 2025 Common Stock 38,974 Direct F3, F6
transaction OGN Restricted Stock Units Options Exercise $0 -21,472 -100% $0.000000 0 31 Mar 2025 Common Stock 21,472 Direct F3, F7
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This price is the closing market price of Organon & Co. ("Organon") common stock on Friday, March 28, 2025, as required by the plan under which the Restricted Stock Units ("RSU") were awarded.
F2 The Reporting Person was granted stock options, which vest and become exercisable in three equal installments on March 31, 2026, March 31, 2027, and March 31, 2028.
F3 Each RSU converts into one share of Organon common stock.
F4 The Reporting Person was granted RSUs, which represent a contingent right to receive one share of Organon common stock for each RSU. On March 31, 2025, RSUs were granted and will vest in three equal installments on each of March 31, 2026, March 31, 2027, and March 31, 2028.
F5 On March 29, 2024, RSUs were granted and on March 29, 2025, one-third of these RSUs vested, with the remaining RSUs to vest on March 29, 2026, and March 29, 2027. Since the first anniversary of the date of grant was on Saturday, March 29, 2025, the vesting occurred on Monday, March 31, 2025, the next business day.
F6 On March 31, 2023, RSUs were awarded and on March 31, 2025, one-third of these RSUs vested with the remaining RSUs to vest on March 31, 2026.
F7 On March 31, 2022, RSUs were awarded and on March 31, 2025, the final third of these RSUs vested.